open access

Vol 6, No 3 (2017)
ORIGINAL ARTICLE
Published online: 2017-09-29
Get Citation

Comparison of hypertension control in patients with diabetes and hypertension and patients with hypertension without diabetes depending on the stage of chronic kidney disease

Anna Markowicz, Władysław Grzeszczak
DOI: 10.5603/DK.2017.0014
·
Clinical Diabetology 2017;6(3):81-89.

open access

Vol 6, No 3 (2017)
ORIGINAL ARTICLE
Published online: 2017-09-29

Abstract

 Diabetes and hypertension are plagues of the begin­ning of the 21st century. Both of these conditions lead to significant deterioration in quality of life and reduc­tion of patient’s life expectancy. The aim of the work was to answer the questions: what is the all day, daily and night systolic and diastolic blood pressure in pa­tients with hypertension and in patients with diabetes and hypertension, depending on the stage of chronic kidney disease, and whether there are significant dif­ferences in the control of day and night systolic and diastolic blood pressure between the patients with diabetes mellitus and hypertension. 300 patients have been admitted to the Department of Internal Diseases, Diabetology and Nephrology due to hypertension decompensation. In the first place all subjects were divided into two groups: the ones with diabetes and hypertension and patients with hypertension but with­out diabetes. Afterwards the patients were divided in 5 subgroups depending on the stage of chronic kidney disease. It was shown that patients with diabetes and hypertension are significantly less likely to have their blood pressure controlled properly (24 hours a day, during the day and at night) in relation to patients with hypertension without diabetes and that, with increased renal failure, diabetes and hypertension and hypertensive patients without diabetes do not have good blood pressure control, especially for diabetics and hypertension. (Clin Diabetol 2017; 6, 3: 81–89)

Abstract

 Diabetes and hypertension are plagues of the begin­ning of the 21st century. Both of these conditions lead to significant deterioration in quality of life and reduc­tion of patient’s life expectancy. The aim of the work was to answer the questions: what is the all day, daily and night systolic and diastolic blood pressure in pa­tients with hypertension and in patients with diabetes and hypertension, depending on the stage of chronic kidney disease, and whether there are significant dif­ferences in the control of day and night systolic and diastolic blood pressure between the patients with diabetes mellitus and hypertension. 300 patients have been admitted to the Department of Internal Diseases, Diabetology and Nephrology due to hypertension decompensation. In the first place all subjects were divided into two groups: the ones with diabetes and hypertension and patients with hypertension but with­out diabetes. Afterwards the patients were divided in 5 subgroups depending on the stage of chronic kidney disease. It was shown that patients with diabetes and hypertension are significantly less likely to have their blood pressure controlled properly (24 hours a day, during the day and at night) in relation to patients with hypertension without diabetes and that, with increased renal failure, diabetes and hypertension and hypertensive patients without diabetes do not have good blood pressure control, especially for diabetics and hypertension. (Clin Diabetol 2017; 6, 3: 81–89)

Get Citation

Keywords

diabetes, hypertension, kidney failure, equalization

About this article
Title

Comparison of hypertension control in patients with diabetes and hypertension and patients with hypertension without diabetes depending on the stage of chronic kidney disease

Journal

Clinical Diabetology

Issue

Vol 6, No 3 (2017)

Pages

81-89

Published online

2017-09-29

DOI

10.5603/DK.2017.0014

Bibliographic record

Clinical Diabetology 2017;6(3):81-89.

Keywords

diabetes
hypertension
kidney failure
equalization

Authors

Anna Markowicz
Władysław Grzeszczak

References (15)
  1. World Health Organization. Global Report on Diabetes, WHO 2016.
  2. IDF Diabetes Atlas Group. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract. 2015; 109(3): 461–465.
  3. Kabakov E, Norymberg C, Osher E, et al. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J. Cardiometab. Syndr. 2006; 1(2): 95–101.
  4. Adler AI. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321(7258): 412–419.
  5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317(7160): 703–713.
  6. Cushman WC, et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N. Engl. J. Med. 2010; 362(17): 1575–1585.
  7. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998; 317(7160): 713–720.
  8. Chen NC, Hsu CY, Chen CL. The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int. 2017; 2017: 9035193.
  9. Taler SJ, Agarwal R, Bakris GL, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013; 62(2): 201–213.
  10. Sarafidis PA, Ruilope LM. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 2014; 85(3): 536–546.
  11. Kabat M. Znaczenie 24-godzinnego pomiaru ciśnienia krwi. Postępy Nauk Medycznych 2002;. ; 2/3: 135–139.
  12. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcomes Quality Initiative. Am. J. Kidney Dis. 2002; 39(supl.1): 17–222.
  13. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733): 2215–2222.
  14. Widecka K, Grodzicki K, Narkiewicz K, et al. Zasady postępowania w nadciśnieniu tętniczym. Nadciśnienie tętnicze. Nadciśnienie tętnicze. 2011; 15: 55–82.
  15. Grupa Robocza Europejskiego Towarzystwa Nadciśnienia Tętniczego (ESH) i Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w nadciśnieniu tętniczym. Wytyczne ESH/ESC dotyczące postępowaniaw nadciśnieniu tętniczym w 2013 roku. Nadciśnienie tętnicze. 2013; 71: 69–168.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl